112 related articles for article (PubMed ID: 2784072)
1. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
2. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
3. The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1.
Juhasz F; Balázs G; Stenszky V; Kozma L; Farid NR
Cancer; 1986 Jul; 58(1):52-4. PubMed ID: 3486708
[TBL] [Abstract][Full Text] [Related]
4. Association of differentiated thyroid carcinoma with HLA-DR7.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
[TBL] [Abstract][Full Text] [Related]
5. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid.
Feinmesser M; Stern S; Mechlis-Frish S; Lubin E; Feinmesser R; Kristt D
Eur J Surg Oncol; 1996 Oct; 22(5):494-501. PubMed ID: 8903492
[TBL] [Abstract][Full Text] [Related]
7. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
8. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract][Full Text] [Related]
9. HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors.
Goldsmith NK; Dikman S; Bermas B; Davies TF; Roman SH
Clin Immunol Immunopathol; 1988 Aug; 48(2):161-73. PubMed ID: 3390969
[TBL] [Abstract][Full Text] [Related]
10. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
12. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
13. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and significance of lymphocyte infiltration in papillary carcinoma of the thyroid gland].
Gómez Saez JM; Gómez Arnaiz N; Sahun de la Vega M; Soler Ramón J
An Med Interna; 1997 Aug; 14(8):403-5. PubMed ID: 9376479
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment?
Larsen B; Thompson C; Kwan A; Farid NR
Tissue Antigens; 1986 Nov; 28(5):298-300. PubMed ID: 3824363
[TBL] [Abstract][Full Text] [Related]
16. Expression of class I and II human leukocyte antigens by thyrocytes and lymphocytic infiltration on human thyroid tumors. An immunofluorescence study.
Betterle C; Presotto F; Caretto A; Pelizzo MR; Pedini B; Girelli ME; Busnardo B
Cancer; 1991 Feb; 67(4):977-83. PubMed ID: 1991267
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
[TBL] [Abstract][Full Text] [Related]
18. Familial occurrence of differentiated, nonmedullary thyroid carcinoma.
Ozaki O; Ito K; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
World J Surg; 1988 Aug; 12(4):565-71. PubMed ID: 3048001
[No Abstract] [Full Text] [Related]
19. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
20. Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain.
Ríos A; Rodríguez JM; Moya MR; Galindo PJ; Canteras M; Alvarez MR; Parrilla P
Cancer; 2004 Jan; 100(2):264-9. PubMed ID: 14716759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
